About Late-onset combined immunodeficiency due to ICOSL deficiency
Late-onset combined immunodeficiency due to ICOSL deficiency is a rare disease catalogued by Orphanet (ORPHA:695191). It is associated with the ICOSLG gene. Search below for active recruiting clinical trials from ClinicalTrials.gov, or visit the Orphanet expert page for specialist centres, natural history studies, and patient registries.
Clinical Trial Eligibility Tips
What to know before applying to Late-onset combined immunodeficiency due to ICOSL deficiency trials.
Search ClinicalTrials.gov for "Late-onset combined immunodeficiency due to ICOSL deficiency" or filter by Orphanet code ORPHA:695191 to find disease-specific studies.
Ask your specialist to refer you to a Centre of Expertise — Orphanet lists all accredited centres for this condition worldwide.
Natural history studies and patient registries often enrol before drug trials open — contact the Orphanet patient community first.
Patient Resources
Find recruiting Late-onset combined immunodeficiency due to ICOSL deficiency trials
Search 500,000+ studies from ClinicalTrials.gov, filtered for Late-onset combined immunodeficiency due to ICOSL deficiency. Updated daily.